A smaller drug manufacturer, MedChem, signed licensing contracts with the MPP before Aurobindo, but Mara said it is likely that the latter will be the first to get medicines to market. "Aurobindo has a track record of producing ARVs, so it is likely that they will be the first," she said. You might also like Patent pool in talks with first potential contributors
Un fabricante de medicamentos más pequeño, MedChem, firmó contratos de licencia con el BPM antes que Aurobindo, pero Mara dijo que es probable que esta última empresa sea la primera en comercializar fármacos.